Our top pick for
Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
Capstead Mortgage Corporation is a reit-mortgage business based in the US. Capstead Mortgage Corporation shares (CMO) are listed on the NYSE and all prices are listed in US Dollars. Capstead Mortgage Corporation employs 15 staff and has a trailing 12-month revenue of around 0.00.
|Latest market close||$16.41|
|52-week range||$5.79 - $6.95|
|50-day moving average||$6.83|
|200-day moving average||$6.53|
|Wall St. target price||$6.75|
|Dividend yield||$0.6 (9.46%)|
|Earnings per share (TTM)||$0.70|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2022-06-26)||N/A|
|1 month (2022-06-03)||N/A|
|3 months (2022-04-03)||N/A|
|6 months (2022-01-03)||N/A|
|1 year (2021-07-07)||171.24%|
|2 years (2020-07-07)||203.89%|
|3 years (2019-07-05)||94.43%|
|5 years (2017-07-07)||57.79%|
Valuing Capstead Mortgage Corporation stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Capstead Mortgage Corporation's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Capstead Mortgage Corporation's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 9x. In other words, Capstead Mortgage Corporation shares trade at around 9x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Capstead Mortgage Corporation's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.28. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Capstead Mortgage Corporation's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
|Revenue TTM||$99.4 million|
|Operating margin TTM||87.4%|
|Gross profit TTM||$-45,665,000|
|Return on assets TTM||1.05%|
|Return on equity TTM||9.73%|
|Market capitalisation||$634 million|
TTM: trailing 12 months
Dividend payout ratio: 1.02% of net profits
Recently Capstead Mortgage Corporation has paid out, on average, around 1.02% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 5.95% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Capstead Mortgage Corporation shareholders could enjoy a 5.95% return on their shares, in the form of dividend payments. In Capstead Mortgage Corporation's case, that would currently equate to about $0.6 per share.
While Capstead Mortgage Corporation's payout ratio might seem low, this can signify that Capstead Mortgage Corporation is investing more in its future growth.
Capstead Mortgage Corporation's most recent dividend payout was on 17 October 2021. The latest dividend was paid out to all shareholders who bought their shares by 11 October 2021 (the "ex-dividend date").
Capstead Mortgage Corporation's shares were split on a 1:2 basis on 1 July 2001. So if you had owned 2 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Capstead Mortgage Corporation shares – just the quantity. However, indirectly, the new 100% higher share price could have impacted the market appetite for Capstead Mortgage Corporation shares which in turn could have impacted Capstead Mortgage Corporation's share price.
Over the last 12 months, Capstead Mortgage Corporation's shares have ranged in value from as little as $5.7861 up to $6.9509. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Capstead Mortgage Corporation's is 1.5439. This would suggest that Capstead Mortgage Corporation's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Capstead Mortgage Corporation operates as a real estate investment trust (REIT) in the United States. It invests in a portfolio of residential mortgage pass-through securities primarily consisting of short-duration adjustable-rate mortgage securities issued and guaranteed by government-sponsored enterprises, or by an agency of the federal government. The company qualifies as a REIT for federal income tax purposes. It generally would not be subject to federal corporate income taxes if it distributes at least 90% of its taxable income to its stockholders. The company was incorporated in 1985 and is headquartered in Dallas, Texas. .
Everything we know about the Citrine Global IPO, plus information on how to buy in.
Everything we know about the Genelux Corporation IPO, plus information on how to buy in.
Everything we know about the Magic Empire Global IPO, plus information on how to buy in.
Everything we know about the Intchains Group IPO, plus information on how to buy in.
Everything we know about the Biostage IPO, plus information on how to buy in.
Everything we know about the Wang & Lee Group IPO, plus information on how to buy in.
Everything we know about the OptMed IPO, plus information on how to buy in.
Everything we know about the Lichen China IPO, plus information on how to buy in.
Everything we know about the LeeWay Services IPO, plus information on how to buy in.
Everything we know about the Nano Labs IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.